MedPath

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy

Not Applicable
Conditions
hematological malignancies oral mucositis associated with cancer therapy
Registration Number
JPRN-UMIN000016948
Lead Sponsor
niversity of Hyogo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients undergoing myeloablative regimens for hematopoietic stem cell transplantation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
condition of oral hygiene include oral mucositis, mouth moist
Secondary Outcome Measures
NameTimeMethod
self-efficacy scale for cancer patients SF-36v2 self-care ability (scale)
© Copyright 2025. All Rights Reserved by MedPath